Deciding the fate of “leftover” embryos
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and
Read MoreThis article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and
Read MoreIn November, a young man named Noland Arbaugh announced he’d be livestreaming from his home for three days straight. His
Read MoreLisa Holligan already had two children when she decided to try for another baby. Her first two pregnancies had come
Read MoreThis article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and
Read MoreWHO California Institute for Regenerative Medicine, Neurona Therapeutics, Vertex Pharmaceuticals WHEN 5 years A quarter-century ago, researchers isolated powerful stem
Read MoreWHO Gilead Sciences, GSK, ViiV Healthcare WHEN 1 to 3 years In June 2024, results from a trial of a
Read MoreA new industrial facility in suburban Seattle is giving off a whiff of futuristic technology. It can safely treat fecal
Read MoreEach year, about half a million Americans are diagnosed with Clostridioides difficile, a common bacterial infection of the large intestine.
Read MoreUS doctors write billions of prescriptions each year. During 2024, though, one type of drug stood out—“wonder drugs” known as
Read More